𝔖 Bobbio Scriptorium
✦   LIBER   ✦

One-week dose titration of extended release galantamine in patients with Alzheimer’s disease

✍ Scribed by Douglas W. Scharre; Thomas Shiovitz; Young Zhu; Joan Amatniek

Book ID
118463517
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
277 KB
Volume
4
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Galantamine: a randomized, double-blind,
Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease
✍ D. Wilkinson; J. Murray 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## Objectives To investigate whether Galantamine significantly improves the core symptoms of Alzheimer's disease (AD). ## Background Galantamine is a reversible, competitive, selective inhibitor of acetylcholinesterase (AChE) that also allosterically modulates nicotinic acetylcholine